X4 Pharmaceuticals, Inc. Common Stock (XFOR) is a publicly traded Healthcare sector company. As of July 27, 2026, XFOR trades at $3.85 with a market cap of $363.13M and a P/E ratio of -20.26. XFOR moved -3.26% today. Year to date, XFOR is -7.45%; over the trailing twelve months it is +110.38%. Its 52-week range spans $1.35 to $26.83. Analyst consensus is strong buy with an average price target of $11.67. Rallies surfaces XFOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for XFOR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.85 |
| Market Cap | $363.13M |
| P/E Ratio | -20.26 |
| EPS | $-0.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.83 |
| 52-Week Low | $1.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.56M |
| Net Income | $-37.45M |
| Gross Margin | 68.83% |
3 analysts cover XFOR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.67.